Oral Pooled Fecal Microbiotherapy to Prevent Allogeneic Hematopoietic Cell Transplantation Complications (PHOEBUS Trial)

NCT05762211 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

387

Enrollment

INDUSTRY

Sponsor class

Conditions

Transplant Complication

Interventions

DRUG: Pooled allogeneic fecal microbiotherapy
DRUG: Placebo

Sponsor

MaaT Pharma